View Post

Improving Accuracy in Predicting Response to Neoadjuvant Treatment in Patients With Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Danielle Garcia From: oncozine.com A liquid biopsy, a sampling and analysis of non-solid biological tissue, primarily blood, is mainly used as a diagnostic and monitoring tool for diseases such as cancer. One of the benefits of liquid biopsies is that they are largely non-invasive. Another advantage is that liquid biopsies may potentially help detect, characterize, and monitor cancers earlier …

View Post

Maverick Therapeutics to Use Inivata’s Liquid Biopsy Assay in Phase I/II Clinical Study

In Clinical Studies News by Barbara Jacoby

By: Staff Reporter 115 From: precisiononcologynews.com Inivata said on Thursday that it has partnered with Maverick Therapeutics to use Inivata’s Radar (Residual Disease and Recurrence) assay to detect and monitor residual disease and recurrence in patients enrolled in Maverick’s Phase I/II clinical study for its MVC-101 drug candidate. As part of the study, the team will use Radar to monitor circulating tumor …

View Post

Discovery Life Sciences Launches SpecimenSeq™: Genomically and Clinically Annotated Biospecimen Sets to Speed Liquid Biopsy and Immunotherapy Development

In Clinical Studies News by Barbara Jacoby

Source: Discovery Life Sciences From: PR Newswire Discovery Life Sciences™ (Discovery) announces the launch of a powerful new tool for liquid biopsy diagnostic assay and oncology drug developers: SpecimenSeq™. SpecimenSeq is a collection of high quality, fully consented biospecimens that include clinical and molecular characterizations to help researchers identify, develop and validate new biomarker signatures for precision medicine applications. SpecimenSeq …

View Post

‘Liquid biopsy’ tech contributes to successful clinical trial for detecting breast cancer recurrence

In Clinical Studies News by Barbara Jacoby

From: purdue.edu Accurately diagnosing the spread of cancer often involves painful and invasive biopsy procedures. The use of a “liquid biopsy,” which involves a simple blood draw, has been shown in a five-year clinical trial to accurately detect and monitor certain kinds of breast cancer. The study involves circulating tumor DNA (ctDNA) and circulating tumor cells (CTC), genetic and cellular …

View Post

Liquid biopsy may predict early-stage TNBC recurrence

In Clinical Studies News by Barbara Jacoby

By: Shreeya Nanda From: medwirenews.com The presence of circulating tumor (ct)DNA and circulating tumor cells (CTCs) in postsurgical samples is associated with relapse and poor outcomes in early-stage triple-negative breast cancer (TNBC) patients with an incomplete pathologic response to neoadjuvant chemotherapy, research suggests. Distant disease-free survival (DDFS), DFS, and overall survival (OS) were significantly worse for patients with versus without …

View Post

Some Good News for 2020 for Cancer Survivors

In In The News by Barbara Jacoby

By: Khevin Barnes From: curetoday.com Khevin Barnes is a Male Breast Cancer survivor, magician and speaker. He is currently writing, composing and producing a comedy stage musical about Male Breast Cancer Awareness. He travels wherever he is invited to speak to (and do a little magic for) men and women about breast cancer. www.BreastCancerSpeaker.com www.MaleBreastCancerSurvivor.com I recently spent five amazing …

View Post

Liquid Biopsy Assay From MSKCC Approved by New York State

In In The News by Barbara Jacoby

By: Staff Reporter From: genomeweb.com Memorial Sloan Kettering Cancer Center said today that New York state has approved the center’s liquid biopsy test for noninvasive cancer genomic profiling and disease monitoring. The test, called Analysis of Circulating cfDNA to Evaluate Somatic Access (MSK-ACCESS), has been clinically validated and implemented by MSK’s molecular diagnostics service. It sequences 129 cancer-associated genes selected …

View Post

Extreme Early Detection Intrigues Cancer Researchers

In In The News by Barbara Jacoby

By: Faye Flam From: bloomberg.com Many tumors grow silently for years before they cause any symptoms. Oncologists see an opportunity. There’s only so far you can go toward preventing cancer with a healthy lifestyle. Bone tumors in fossils show that people have been getting cancer since prehistoric times — before smoking, before modern diets, even before the dawn of our …

View Post

New Study: Blood Test Offers Improved Breast Cancer Detection, New Tool to Reduce Use of Breast Biopsy

In In The News by Barbara Jacoby

Source: Provista Diagnostics From: PR Newswire Study of Videssa® Breast shows “liquid biopsy” after abnormal mammogram and other imaging can help rule out breast cancer, reduce breast biopsy by up to 67 percent in women under age 50 A new study published in Clinical Breast Cancer demonstrates that Videssa® Breast, a multi-protein biomarker blood test to detect breast cancer, can …

View Post

Liquid Biopsies Using Carbon Nanotube Semiconductors Show Promise For Early Cancer Detection

In In The News by Barbara Jacoby

By: Kevin Murnane From: forbes.com My wife is alive today because five years ago her difficult-to-detect form of breast cancer was identified very early. She is not alone; early cancer detection has saved many lives and with improved diagnostic technologies it could save many more. A recently developed liquid biopsy that makes use of carbon nanotube (CNT) semiconductors is a …